M, Bellet et al.
 Dose Selection for Clinical Development in the Treatment of Hypertension: The Aprocitentan Case and Lessons from the Past.
<strong>Medical Research Archives</strong>, [S.l.], v. 12, n. 1, jan. 2024.
ISSN 2375-1924.
Available at: &lt;<a href="https://esmed.org/MRA/mra/article/view/4962" target="_new">https://esmed.org/MRA/mra/article/view/4962</a>&gt;. Date accessed: 22 dec. 2024.
doi: <a href="https://doi.org/10.18103/mra.v12i1.4962">https://doi.org/10.18103/mra.v12i1.4962</a>.